Daniel Kirby

3.7k total citations · 1 hit paper
58 papers, 2.8k citations indexed

About

Daniel Kirby is a scholar working on Molecular Biology, Pharmaceutical Science and Immunology. According to data from OpenAlex, Daniel Kirby has authored 58 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Pharmaceutical Science and 12 papers in Immunology. Recurrent topics in Daniel Kirby's work include RNA Interference and Gene Delivery (10 papers), Immunotherapy and Immune Responses (10 papers) and Drug Solubulity and Delivery Systems (8 papers). Daniel Kirby is often cited by papers focused on RNA Interference and Gene Delivery (10 papers), Immunotherapy and Immune Responses (10 papers) and Drug Solubulity and Delivery Systems (8 papers). Daniel Kirby collaborates with scholars based in United Kingdom, United States and Denmark. Daniel Kirby's co-authors include Yvonne Perrie, Afzal R. Mohammed, Vincent W. Bramwell, Peter Andersen, Else Marie Agger, Sarah E. McNeil, Ida Rosenkrands, Dennis Christensen, A. Vangala and Jesper Rømhild Davidsen and has published in prestigious journals such as New England Journal of Medicine, Analytical Chemistry and Scientific Reports.

In The Last Decade

Daniel Kirby

56 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults

2014 549 citations Carlos A. DiazGranados, Andrew J. Dunning et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Kirby United Kingdom	27	858	748	679	364	363	58	2.8k
Kevin O. Kisich United States	17	714 0.8×	644 0.9×	237 0.3×	254 0.7×	251 0.7×	24	2.4k
Stanley A. Schwartz United States	44	2.0k 2.4×	1.7k 2.2×	676 1.0×	105 0.3×	578 1.6×	196	6.9k
Mark A. Suckow United States	34	1.4k 1.6×	451 0.6×	231 0.3×	165 0.5×	264 0.7×	140	4.2k
Henrik Sjövall Sweden	32	2.8k 3.3×	898 1.2×	597 0.9×	291 0.8×	511 1.4×	109	6.2k
Enno C.I. Veerman Netherlands	52	2.8k 3.2×	857 1.1×	456 0.7×	75 0.2×	480 1.3×	145	7.6k
You Zhou United States	34	1.4k 1.7×	529 0.7×	488 0.7×	87 0.2×	527 1.5×	87	3.6k
James M. Brewer United Kingdom	41	1.3k 1.5×	3.6k 4.8×	862 1.3×	269 0.7×	469 1.3×	144	6.5k
Daniel Malamud United States	45	1.7k 1.9×	515 0.7×	884 1.3×	109 0.3×	924 2.5×	153	6.1k
Frank G. Oppenheim United States	51	3.0k 3.5×	404 0.5×	466 0.7×	78 0.2×	479 1.3×	130	7.9k
Patrick J. Tighe United Kingdom	39	1.8k 2.1×	1.2k 1.5×	365 0.5×	41 0.1×	296 0.8×	129	4.7k

Countries citing papers authored by Daniel Kirby

Since Specialization

Citations

This map shows the geographic impact of Daniel Kirby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Kirby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Kirby more than expected).

Fields of papers citing papers by Daniel Kirby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Kirby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Kirby. The network helps show where Daniel Kirby may publish in the future.

Co-authorship network of co-authors of Daniel Kirby

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Kirby. A scholar is included among the top collaborators of Daniel Kirby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Kirby. Daniel Kirby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kirby, Daniel, et al.. (2024). Buccal Absorption of Biopharmaceutics Classification System III Drugs: Formulation Approaches and Mechanistic Insights. Pharmaceutics. 16(12). 1563–1563. 7 indexed citations

Kirby, Daniel, et al.. (2024). Systematic screening of photopolymer resins for stereolithography (SLA) 3D printing of solid oral dosage forms: Investigation of formulation factors on printability outcomes. International Journal of Pharmaceutics. 653. 123862–123862. 9 indexed citations

Badhan, Raj, et al.. (2023). Virtual Clinical Trials Guided Design of an Age-Appropriate Formulation and Dosing Strategy of Nifedipine for Paediatric Use. Pharmaceutics. 15(2). 556–556. 1 indexed citations

Kirby, Daniel, et al.. (2022). Paediatric specific dosage forms: Patient and formulation considerations. International Journal of Pharmaceutics. 616. 121501–121501. 52 indexed citations

Rajabi‐Siahboomi, Ali R., et al.. (2021). Multi-Analytical Framework to Assess the In Vitro Swallowability of Solid Oral Dosage Forms Targeting Patient Acceptability and Adherence. Pharmaceutics. 13(3). 411–411. 11 indexed citations

Dahmash, Dania, et al.. (2020). Does the Formulation of Oral Solid Dosage Forms Affect Acceptance and Adherence in Older Patients? A Mixed Methods Systematic Review. Journal of the American Medical Directors Association. 21(8). 1015–1023.e8. 32 indexed citations

Rajabi‐Siahboomi, Ali R., et al.. (2019). Conceptualisation, Development, Fabrication and In Vivo Validation of a Novel Disintegration Tester for Orally Disintegrating Tablets. Scientific Reports. 9(1). 12467–12467. 16 indexed citations

Hussain, Maryam T., Carla B. Roces, Giulia Anderluzzi, et al.. (2016). Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic and lipophilic drugs. International Journal of Pharmaceutics. 514(1). 160–168. 143 indexed citations

Perrie, Yvonne, Habib Ali, Daniel Kirby, et al.. (2016). Environmental Scanning Electron Microscope Imaging of Vesicle Systems. Methods in molecular biology. 131–143. 4 indexed citations

10.

DiazGranados, Carlos A., Andrew J. Dunning, Murray Kimmel, et al.. (2014). Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults. New England Journal of Medicine. 371(7). 635–645. 549 indexed citations breakdown →

11.

Kirby, Daniel, et al.. (2011). Time to strengthen the evidence base for paediatric formulations. Aston Publications Explorer (Aston University). 1 indexed citations

12.

Plennevaux, Eric, et al.. (2011). Influenza A (H1N1) 2009 two-dose immunization of US children: An observer-blinded, randomized, placebo-controlled trial. Vaccine. 29(8). 1569–1575. 30 indexed citations

13.

Perrie, Yvonne, Habib Ali, Daniel Kirby, et al.. (2009). Environmental Scanning Electron Microscope Imaging of Vesicle Systems. Methods in molecular biology. 1522. 319–331. 6 indexed citations

14.

Christensen, Dennis, Daniel Kirby, Camilla Foged, et al.. (2008). α,α′-trehalose 6,6′-dibehenate in non-phospholipid-based liposomes enables direct interaction with trehalose, offering stability during freeze-drying. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1778(5). 1365–1373. 34 indexed citations

15.

Kirby, Daniel, Ida Rosenkrands, Else Marie Agger, et al.. (2008). Liposomes act as stronger sub-unit vaccine adjuvants when compared to microspheres. Journal of drug targeting. 16(7-8). 543–554. 26 indexed citations

16.

Batchelor, Hannah, et al.. (2007). Drug Delivery. Journal of Pharmacy and Pharmacology. 59(Supplement_1). A–31. 2 indexed citations

17.

Perrie, Yvonne, Daniel Kirby, Vincent W. Bramwell, & Afzal R. Mohammed. (2007). Recent Developments in Particulate-Based Vaccines. Recent Patents on Drug Delivery & Formulation. 1(2). 117–129. 25 indexed citations

18.

Kirby, Daniel & Brian S. Ickes. (2006). Temporal and Spatial Trends in the Frequency of Occurrence, Length-Frequency Distributions, Length-Weight Relationships, and Relative Abundance of Upper Mississippi River Fish. Defense Technical Information Center (DTIC). 2 indexed citations

19.

Davidsen, Jesper Rømhild, Ida Rosenkrands, Dennis Christensen, et al.. (2005). Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6′-dibehenate)—A novel adjuvant inducing both strong CMI and antibody responses. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1718(1-2). 22–31. 285 indexed citations

20.

Nashabeh, Wassim, Daniel Kirby, František Foret, et al.. (1994). Incorporation of hydrophobic selectivity in capillary electrophoresis: analysis of recombinant insulin-like growth factor I variants. Analytical Chemistry. 66(13). 2148–2154. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact